Lakefront Biotherapeutics NV SEC filings GLPGF
Lakefront Biotherapeutics NV has 545 filings in SEC EDGAR's recent list, going back to Nov 14, 2007. Its latest annual report, Form 20-F, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 4, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | May 8, 2026 | — |
| S-8 | Employee stock plan registration | Dec 10, 2025 | — |
| S-8 | Employee stock plan registration | Nov 20, 2024 | — |
| S-8 | Employee stock plan registration | Dec 4, 2023 | — |
| S-8 | Employee stock plan registration | Dec 12, 2022 | — |
| S-8 | Employee stock plan registration | Oct 26, 2021 | — |
| S-8 | Employee stock plan registration | Oct 9, 2020 | — |
| S-8 | Employee stock plan registration | May 24, 2019 | — |
| F-3ASR | Filing | Mar 29, 2019 | — |
| 424B3 | Prospectus | Oct 15, 2018 | — |
| 424B5 | Prospectus supplement | Sep 14, 2018 | — |
| 424B5 | Prospectus supplement | Sep 13, 2018 | — |
| S-8 | Employee stock plan registration | May 29, 2018 | — |
| S-8 | Employee stock plan registration | May 22, 2017 | — |
| 424B5 | Prospectus supplement | Apr 18, 2017 | — |
| 424B5 | Prospectus supplement | Apr 17, 2017 | — |
| S-8 | Employee stock plan registration | Jan 27, 2017 | — |
| S-8 | Employee stock plan registration | Jun 3, 2016 | — |
| F-3ASR | Filing | Jun 1, 2016 | — |
| S-8 | Employee stock plan registration | Dec 22, 2015 | — |
| S-8 | Employee stock plan registration | May 29, 2015 | — |
| 424B4 | Prospectus | May 14, 2015 | — |
| F-1MEF | Filing | May 13, 2015 | — |
| F-1/A | Filing | May 12, 2015 | — |
| FWP | Free writing prospectus | May 12, 2015 | — |
| F-1/A | Filing | May 11, 2015 | — |
| F-1/A | Filing | May 7, 2015 | — |
| F-1/A | Filing | May 5, 2015 | — |
| F-1/A | Filing | Apr 30, 2015 | — |
| F-6 | Filing | Apr 23, 2015 | — |
| F-1 | Registration statement (foreign issuer) | Apr 15, 2015 | — |
| F-6 | Form f-6 | Mar 7, 2008 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LKFT (Nasdaq), GLPGF (OTC)
- Incorporated in
- Belgium
- Headquarters
- 2800 Mechelen
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1421876
- Former names
- GALAPAGOS NV (until May 6, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.